"Anticancer drugs" trang 1 - tải miễn phí từ tailieunhanh
Evaluation the effect of several anticancer drugs on Vietnamese breast cancer cells

Evaluation the effect of several anticancer drugs on Vietnamese breast cancer cells
8    108    0
A review on anticancer potential of natural drugs: Hispolon and limonene

A review on anticancer potential of natural drugs: Hispolon and limonene
11    74    1
An insight into the therapeutic potential of piperazine-based anticancer agents

An insight into the therapeutic potential of piperazine-based anticancer agents
23    76    1
Ebook New approaches to natural anticancer drugs

Ebook New approaches to natural anticancer drugs
117    4    1
A comprehensive evaluation of potentially significant drug-drug, drug-herb, and drug-food interactions among cancer patients receiving anticancer drugs

A comprehensive evaluation of potentially significant drug-drug, drug-herb, and drug-food interactions among cancer patients receiving anticancer drugs
11    34    1
Treatment with anticancer drugs for advanced pancreatic cancer: A systematic review

Treatment with anticancer drugs for advanced pancreatic cancer: A systematic review
16    1    1
Pt(IV), Pd(II), and Rh(III) complexes induced oxidative stress and cytotoxicity in the HCT-116 colon cancer cell line

Pt(IV), Pd(II), and Rh(III) complexes induced oxidative stress and cytotoxicity in the HCT-116 colon cancer cell line
7    85    0
Response rate of anticancer drugs approved by the Food and Drug Administration based on a single-arm trial

Response rate of anticancer drugs approved by the Food and Drug Administration based on a single-arm trial
11    22    1
KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer

KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer
16    50    1
PEGylated Protein Drugs: Basic Science and Clinical Applications

PEGylated Protein Drugs: Basic Science and Clinical Applications
299    60    0
ONCOGENOMICS AND CANCER PROTEOMICS – NOVEL APPROACHES IN BIOMARKERS DISCOVERY AND THERAPEUTIC TARGETS IN CANCER

ONCOGENOMICS AND CANCER PROTEOMICS – NOVEL APPROACHES IN BIOMARKERS DISCOVERY AND THERAPEUTIC TARGETS IN CANCER

238    54    0
Pluronic – Grafted Copolymers as Nanoplatforms for

Pluronic – Grafted Copolymers as Nanoplatforms for
11    85    0
Publication statuses of clinical trials supporting FDA-approved immune checkpoint inhibitors: A metaepidemiological investigation

Publication statuses of clinical trials supporting FDA-approved immune checkpoint inhibitors: A metaepidemiological investigation
10    77    0
Key actors in cancer therapy: Epigenetic modifiers

Key actors in cancer therapy: Epigenetic modifiers
16    45    1
Investigation of the structural and physicochemical requirements of quinoline-arylamidine hybrids for the growth inhibition of K562 and Raji leukemia cells

Investigation of the structural and physicochemical requirements of quinoline-arylamidine hybrids for the growth inhibition of K562 and Raji leukemia cells
16    39    1
Recent advances in thymidine phosphorylase inhibitors: syntheses and prospective medicinal applications

Recent advances in thymidine phosphorylase inhibitors: syntheses and prospective medicinal applications
28    34    3
Bioaccumulation and toxicity of oxaliplatin in fresh water: A study with Lemna minor

Bioaccumulation and toxicity of oxaliplatin in fresh water: A study with Lemna minor
6    64    3
Streptozotocin induces alpha-2u globulin nephropathy in male rats during diabetic kidney disease

Streptozotocin induces alpha-2u globulin nephropathy in male rats during diabetic kidney disease
9    22    1
Efficacy of donepezil for the treatment of oxaliplatin-induced peripheral neuropathy: DONEPEZOX, a protocol of a proof of concept, randomised, triple-blinded and multicentre trial

Efficacy of donepezil for the treatment of oxaliplatin-induced peripheral neuropathy: DONEPEZOX, a protocol of a proof of concept, randomised, triple-blinded and multicentre trial
11    22    1
Anti-proliferative activity of RIHMSQi-23 against MCF-7 breast cancer cell line is through inhibition of cell proliferation and senescence but not inhibition of targeted kinases

Anti-proliferative activity of RIHMSQi-23 against MCF-7 breast cancer cell line is through inhibition of cell proliferation and senescence but not inhibition of targeted kinases
12    1    1